ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MRUS Merus NV

54.24
-1.53 (-2.74%)
Jun 18 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Merus NV MRUS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-1.53 -2.74% 54.24 19:00:00
Open Price Low Price High Price Close Price Previous Close
55.76 53.92 55.92 54.24 55.77
more quote information »

Recent News

Date Time Source Heading
6/17/202414:37EDGAR2Form 144 - Report of proposed sale of securities
6/12/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/06/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/03/202413:30GLOBEMerus’ MCLA-129 Demonstrates Promising Single-Agent..
6/02/202411:30GLOBEMerus Presents Interim Data on MCLA-145 Monotherapy and in..
5/30/202416:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/29/202420:30GLOBEMerus Announces Pricing of Upsized Public Offering of Common..
5/29/202407:00GLOBEMerus to Participate in a Fireside Chat at the Jefferies..
5/28/202415:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
5/28/202415:06EDGAR2Form 8-K - Current report
5/28/202415:01GLOBEMerus N.V. Announces Proposed Public Offering of Common..
5/28/202406:00GLOBEMerus’ Petosemtamab in Combination with Pembrolizumab..
5/23/202416:00GLOBEMerus Announces Publication of an Abstract on Petosemtamab..
5/13/202407:00GLOBEPetosemtamab granted Breakthrough Therapy Designation by the..
5/10/202415:33EDGAR2Form 8-K/A - Current report: [Amend]
5/09/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/08/202415:15GLOBEMerus Announces Financial Results for the First Quarter 2024..
5/08/202407:01EDGAR2Form 8-K - Current report
5/06/202415:05GLOBEMerus Announces U.S. FDA Acceptance and Priority Review of..
4/08/202411:00GLOBEMerus Presents Preclinical Data Demonstrating Efficacy of..
4/03/202407:00GLOBEMerus to Participate in a Fireside Chat at the 23rd Annual..
3/06/202407:15EDGAR2Form 8-K - Current report
3/06/202407:00BWGilead and Merus Announce Collaboration to Discover Novel..
3/05/202415:30GLOBEMerus Announces Publication of an Abstract for Presentation..
3/04/202407:00GLOBEMerus to Participate in a Fireside Chat at the Leerink..
2/28/202415:55EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2/28/202415:15GLOBEMerus Announces Financial Results for the Fourth Quarter and..
2/14/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202407:00GLOBEMerus to Participate in Upcoming Investor Conferences
12/20/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202318:29EDGAR2Form 144 - Report of proposed sale of securities
12/12/202315:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/02/202319:40GLOBEMerus Presents Interim Data on MCLA-129 at ESMO Asia..
12/01/202309:47EDGAR2Form 144 - Report of proposed sale of securities
11/26/202310:05GLOBEMerus Announces Publication of Abstracts on MCLA-129 for..
11/02/202315:12GLOBEMerus Announces Financial Results for the Third Quarter 2023..
11/02/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/202307:00GLOBEMerus to Participate in Upcoming Investor Conferences
10/23/202306:30GLOBEMerus’ Zeno Interim Data Continues to Demonstrate Robust and..
10/15/202318:58GLOBEMerus Announces Business Update Conference Call
10/11/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock